Stockscreener 앱 받기
3.56
5.82%
-0.22
시간 외 거래:
3.80
0.24
+6.74%
전일 마감가:
$3.78
열려 있는:
$3.77
하루 거래량:
95,398
Relative Volume:
0.98
시가총액:
$30.98M
수익:
-
순이익/손실:
$-4.69M
주가수익비율:
-1.5279
EPS:
-2.33
순현금흐름:
$-3.81M
1주 성능:
-8.72%
1개월 성능:
-12.10%
6개월 성능:
+25.80%
1년 성능:
+48.33%
1일 변동 폭
$3.50
$3.785
1주일 범위
$3.50
$4.02
52주 변동 폭
$0.64
$6.26
Lixte Biotechnology Holdings Inc Stock (LIXT) Company Profile
명칭
Lixte Biotechnology Holdings Inc
전화
310 203 2902
주소
433 PLAZA REAL, BOCA RATON
LIXT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIXT
Lixte Biotechnology Holdings Inc
|
3.56 | 32.90M | 0 | -4.69M | -3.81M | -2.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lixte Biotechnology Holdings Inc 주식(LIXT)의 최신 뉴스
Will Lixte Biotechnology Holdings Inc. (8640) stock deliver compounding returns2026 world cup usa national team quarterfinals young talents transition play winner prediction breakdown - Улправда
Aug Decliners: Why Lixte Biotechnology Holdings Inc. (8640) stock is listed among top recommendationsInsider Buying & Weekly Momentum Stock Picks - moha.gov.vn
What analysts say about Lixte Biotechnology Holdings Inc 8640 stockCandlestick Trading Patterns & High Return Stock Picks - earlytimes.in
What analysts say about SBCWW stockTechnical Breakout Signals & Free Wealth Planning Blueprints - earlytimes.in
Should You Add Aster DM Healthcare Limited Stock to Your Portfolio NowResistance Breakout Alerts & Minimal Capital Growth - earlytimes.in
Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuationAnalyst Upgrades & Free High Yield Investment Strategies - bollywoodhelpline.com
Lixte Simplifies Capital Structure via Share Exchange Deal - TipRanks
Price Clustering Detected in Anupam Finserv Limited StockLong-Term Investment Plans & Low Risk High Yield - bollywoodhelpline.com
Will Lixte Biotechnology Holdings Inc. stock see insider buyingTake Profit Strategies & Low Entry Investment Portfolio - Bollywood Helpline
LIXTE expands clinical trial for ovarian cancer treatment By Investing.com - Investing.com Australia
Lixte Expands LB-100 Ovarian Cancer Trial Collaboration - TipRanks
Lixte expands LB-100 ovarian cancer trial collaboration - MSN
Key facts: Lixte Biotechnology secures $4.3M funding; expands cancer collaboration - TradingView — Track All Markets
LIXTE expands clinical trial for ovarian cancer treatment - Investing.com India
Lixte Biotechnology Holdings expands collaboration with University of Texas MD Anderson Cancer Center & GSK for LB-100 - marketscreener.com
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial - InvestorNews
Experimental ovarian cancer trial doubles the number of patients it will enroll - Stock Titan
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering - Investing.com Nigeria
Lixte Biotechnology Announces New Registered Direct Offering - TipRanks
Lixte Biotechnology Signs Multiple Material Agreements - TradingView — Track All Markets
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering By Investing.com - Investing.com South Africa
Lixte Biotechnology stock falls after $4.3 million direct offering - Investing.com
Lixte Biotechnology stock falls after $4.3 million direct offering By Investing.com - Investing.com Canada
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering - The Manila Times
Will Lixte Biotechnology Holdings Inc. stock keep outperforming rivalsJuly 2025 Setups & Advanced Technical Signal Analysis - Улправда
Whale Trades: Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyMarket Growth Report & Entry and Exit Point Strategies - Улправда
Profit Recap: What sentiment indicators say about Lixte Biotechnology Holdings Inc stockJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - moha.gov.vn
Momentum Shift: Is Lixte Biotechnology Holdings Inc. stock trading at a premium valuation2025 Analyst Calls & Fast Entry Momentum Trade Alerts - Улправда
Can Lixte Biotechnology Holdings Inc. Equity Warrant stock deliver consistent earnings growthPortfolio Gains Report & Fast Momentum Entry Tips - Улправда
What Wall Street predicts for Lixte Biotechnology Holdings Inc. Equity Warrant stock pricePortfolio Return Report & Daily Profit Maximizing Trade Tips - Улправда
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock a contrarian buyTrade Risk Summary & Weekly Market Pulse Alerts - Улправда
Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesInsider Buying & Expert Approved Trade Ideas - Улправда
Can Lixte Biotechnology Holdings Inc. stock continue upward trendPortfolio Update Summary & Real-Time Volume Triggers - ulpravda.ru
Will Lixte Biotechnology Holdings Inc. stock outperform tech sector in 2025Share Buyback & Stepwise Trade Execution Plans - Улправда
Why Lixte Biotechnology Holdings Inc. stock is a value investor pickJuly 2025 Trade Ideas & Scalable Portfolio Growth Ideas - DonanımHaber
Is Lixte Biotechnology Holdings Inc. Equity Warrant stock attractive for hedge funds2025 Technical Overview & Community Verified Watchlist Alerts - Улправда
Is Lixte Biotechnology Holdings Inc. (8640) stock nearing a technical breakoutQuarterly Profit Summary & Advanced Swing Trade Entry Alerts - DonanımHaber
What dividend safety rating applies to Lixte Biotechnology Holdings Inc. (8640) stockWeekly Trend Recap & AI Forecasted Entry/Exit Points - DonanımHaber
Will Lixte Biotechnology Holdings Inc. stock split again soon2025 Geopolitical Influence & Advanced Technical Signal Analysis - Улправда
Lixte Biotechnology shares dip after $4.3 million registered direct offering - MSN
Why Lixte Biotechnology Holdings Inc. (8640) stock is listed among top recommendationsMarket Activity Recap & Real-Time Volume Spike Alerts - Улправда
Lixte Biotechnology raises $4.3 million in registered direct offering By Investing.com - Investing.com India
Aug Sentiment: Is Lixte Biotechnology Holdings Inc. stock a buy before product launchesPortfolio Profit Report & Weekly High Potential Alerts - Улправда
Insider Trends: Will Lixte Biotechnology Holdings Inc. stock see insider buyingJuly 2025 Short Interest & Trade Opportunity Analysis Reports - Улправда
Lixte Biotechnology Launches $4.3 Million Registered Direct Offering - marketscreener.com
History Review: Will Lixte Biotechnology Holdings Inc. stock see insider buyingGap Up & Reliable Volume Spike Alerts - Улправда
Lixte Biotechnology prices $4.3M registered direct offering - MSN
Lixte Biotechnology Holdings Inc (LIXT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):